so a single man has raised 3/4 of a billion dollars, oversees 5 biotech companies, and sold a single drug for half a billion dollars.... and that's a bad thing?
oh and the poor retail investors, the share price only rose 3000% or so from 2c to 60c in just over a year.
And if you've ever bothered to read up on the pharma world, drugs are constantly getting bought and shelved. it's the exact reason Yuman Fong went with IMU, so he could continue his work unhindered and without the fear of it being put on the back burner.
Phase 3 are extremely expensive which is why smaller bio techs aim for a buy out by then. So in all of your whinging you contradict yourself as on one hand you're whinging that he does cap raises (needed for expensive trials) but you're also whinging he his drugs don't reach phase 3 (a phase that costs hundreds of millions) which would require cap raises. Make your mind up.
you and your cheerleader @SENARIS need to do a bit of research I think. No idea.
IMU Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)